Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis

Journal of Psychopharmacology

Volumn 29, Issue 7, 2015, Pages 753-763

  Cooper, Ruth E ^a   Tye, Charlotte ^a   Kuntsi, Jonna ^a   Vassos, Evangelos ^a   Asherson, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; cognition; meta analysis; omega 3; randomised controlled trial

Indexed keywords

OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; ATTENTION DEFICIT DISORDER; COGNITION; DIET SUPPLEMENTATION; DRUG EFFICACY; HUMAN; MENTAL DISEASE; MENTAL PERFORMANCE; META ANALYSIS (TOPIC); POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPONSE TIME; SHORT TERM MEMORY; SYSTEMATIC REVIEW (TOPIC); ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DIETARY SUPPLEMENT; DRUG EFFECTS; META ANALYSIS;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COGNITION; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; MEMORY, SHORT-TERM; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84934886753     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115587958     Document Type: Article

References (69)

1. Aberg MAL, Aberg N, Brisman J, et al. Fish intake of Swedish male adolescents is a predictor of cognitive performance. Acta Paediatr. 2009 ; 98: 555-560
2. Amminger GP, Schafer MR, Papageorgiou K, et al. Long-chain -3 fatty acids for indicated prevention of psychotic disorders. Arch General Psychiatry. 2010 ; 67: 146-154
3. Antypa N, Van der Does AJW, Smelt AHM, et al. Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol. 2009 ; 23: 831-840
4. Assisi A, Banzi R, Buonocore C, et al. Fish oil and mental health: The role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int Clin Psychopharmacol. 2006 ; 21: 319-336
5. Banaschewski T, Coghill D, Santosh P, et al. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry. 2006 ; 15: 476-495
6. Baumgartner J, Smuts CM, Malan L, et al. Effects of iron and n-3 fatty acid supplementation, alone and in combination, on cognition in school children: A randomized, double-blind, placebo-controlled intervention in South Africa. Am J Clin Nutr. 2012 ; 96: 1327-1338
7. Bédard A-CV, Stein MA, Halperin JM, et al. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2015 ; 56: 40-48
8. Benton D, Donohoe RT, Clayton DE, et al. Supplementation with DHA and the psychological functioning of young adults. Br J Nutr. 2013 ; 109: 155-161
9. Bloch MH, Qawasmi A. Omega-3 Fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011 ; 50: 991-1000
10. Bryan J, Ph D, Osendarp S, et al. Nutrients for cognitive development in school-aged children. Nutr Rev. 2004 ; 62: 295-306
11. Coghill DR, Rhodes SM, Matthews K. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007 ; 62: 954-962
12. Coghill DR, Seth S, Pedroso S, et al Biol Psychiatry. Elsevier ; 2014: 603-615.
13. Cohen J Statistical Power Analysis for the Behavioural Sciences. 1988 ) Statistical Power Analysis for the Behavioural Sciences. 2nd ed.Hillsdale New Jersey: Erlbaum. Hillsdale New Jersey: Erlbaum ; 1988 :
14. Dalton A, Wolmarans P, Witthuhn RC, et al. A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fatty Acid. 2009 ; 80: 143-149
15. Doyle AE, Willcutt EG, Seidman LJ, et al. Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry. 2005 ; 57: 1324-1335
16. Dunnick JK, Hailey JR. Experimental studies on the long-term effects of methylphenidate hydrochloride. Toxicology. 1995 ; 103: 77-84
17. Elbourne DR, Altman DG, Higgins JPT, et al. Meta-analyses involving cross-over trials: Methodological issues. Int J Epidemiol. 2002 ; 31: 140-149
18. Faraone S V, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eurn Child Adolesc Psychiatry. 2010 ; 19: 353-364
19. Field AP, Gillett R. How to do a meta-analysis. Br J Math Stat Psychol. 2010 ; 63: 665-694
20. Frazier TW, Demaree HA, Youngstrom EA. Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology. 2004 ; 18: 543-555
21. Goyens PLL, Spilker ME, Zock PL, et al. Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. J Lipid Res. 2005 ; 46: 1474-1483
22. Greenberg LM, Kindschi CL T.O.V.A. Test of Variables of Attention: Clinical Guide. Los Alamitos, California: Universal Attention Disorders Inc ; 1996 :
23. Gustafsson P, Birberg-Thornberg U, Duchén K, et al. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr. 2010 ; 99: 1540-1549
24. Hamazaki T, Sawazaki S, Itomura M, et al. Rapid publication the effect of docosahexaenoic acid on aggression in young adults. J Clin Invest. 1996 ; 97: 1129-1133
25. Hibbeln JR, Davis JM, Steer C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study. Lancet. 2007 ; 369: 578-585
26. HigginsJPTGreenS (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available at www.cochrane-handbook.org
27. Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr. 2004 ; 58: 467-473
28. Horrocks L a, Yeo YK. Health benefits of docosahexaenoic acid (DHA). Pharmacoll Res. 1999 ; 40: 211-225
29. Jackson P, Deary ME, Reay JL, et al. No effect of 12 weeks' supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18-35 years. Br J Nutr. 2012 ; 107: 1232-1243
30. Kairaluoma L, Närhi V, Ahonen T, et al. Do fatty acids help in overcoming reading difficulties? A double-blind, placebo-controlled study of the effects of eicosapentaenoic acid and carnosine supplementation on children with dyslexia. Child Care Health Dev. 2009 ; 35: 112-119
31. Kalmijn S, van Boxtel MPJ, Ocké M, et al. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004 ; 62: 275-280
32. Karr JE, Grindstaff TR, Alexander JE. Omega-3 polyunsaturated fatty acids and cognition in a college-aged population. Exp Clin Psychopharmacol. 2012 ; 20: 236-242
33. Kennedy DO, Jackson P a, Elliott JM, et al. Cognitive and mood effects of 8 weeks' supplementation with 400 mg or 1000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutr Neurosci. 2009 ; 12: 48-56
34. Kirby A, Woodward A, Jackson S, et al. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res Dev Disabil. 2010 ; 31: 718-730
35. Kuntsi J, Wood AC, Van Der Meere J, et al. Why cognitive performance in ADHD may not reveal true potential: Findings from a large population-based sample. J Int Neuropsychol Soc JINS. 2009 ; 15: 570-579
36. Leonard BE, McCartan D, White J, et al. Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol. 2004 ; 19: 151-180
37. Long S, Benton D. A double-blind trial of the effect of docosahexaenoic acid and vitamin and mineral supplementation on aggression, impulsivity, and stress. Hum Psychopharmacol. 2013 ; 28: 238-247
38. Mazereeuw G, Lanctôt KL, Chau S a, et al. Effects of ω-3 fatty acids on cognitive performance: A meta-analysis. Neurobiol Aging. 2012 1482 ; 33: e17-29
39. McNamara RK, Able J, Jandacek R, et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: A placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr. 2010 ; 91: 1060-1067
40. Milte CM, Parletta N, Buckley JD, et al. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: A randomized controlled trial. Nutrition. 2012 ; 28: 670-677
41. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS medicine. 2009 ; 6 :
42. Morris SB. Estimating effect sizes from pretest-posttest-control group designs. Organizational Research Methods. 2007 ; 11: 364-386
43. Nasrallah H A, Loney J, Olson SC, et al. Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res. 1986 ; 17: 241-246
44. Nigg JT, Willcutt EG, Doyle AE, et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: Do we need neuropsychologically impaired subtypes?. Biol Psychiatry. 2005 ; 57: 1224-1230
45. Ortego C, Botella J. The hard but necessary task of gathering order-one effect size indices in meta-analysis. Psicológica. 2010 ; 31: 291-315
46. Osendarp SJM, Baghurst KI, Bryan J, et al. Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 Parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am J Clin Nutr. 2007 ; 86: 1082-1093
47. Parletta N, Cooper P, Gent DN, et al. Effects of fish oil supplementation on learning and behaviour of children from Australian Indigenous remote community schools: A randomised controlled trial. Prostaglandins Leukot Essent Fatty Acid. 2013 ; 89: 71-79
48. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002 ; 59: 913-919
49. Portillo-Reyes V, Pérez-García M, Loya-Méndez Y, et al. Clinical significance of neuropsychological improvement after supplementation with omega-3 in 8-12 years old malnourished Mexican children: A randomized, double-blind, placebo and treatment clinical trial. Res Dev Disabil. 2014 ; 35: 861-870
50. Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry. 2006 ; 18: 155-172
51. Richardson AJ, Montgomery P. The Oxford-Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005 ; 115: 1360-1366
52. Richardson AJ, Burton JR, Sewell RP, et al. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: A randomized, controlled trial (the DOLAB Study). PloS One. 2012 ; 7: e43909
53. Ryan AS, Nelson EB. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: A randomized, placebo-controlled, double-blind study. Clin Pediatr (Phila). 2008 ; 47: 355-362
54. Schulz KP, Fan J, Be A V. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2014 ; 69: 952-961
55. Simmer K, Patole SK, Rao SC. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev. 2011 ; 12: 1-72
56. Sinn N, Bryan J, Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: A randomised controlled trial. Prostaglandins Leukot Essent Fatty Acid. 2008 ; 78: 311-326
57. Sonuga-Barke E, Bitsakou P, Thompson M. Beyond the dual pathway model: Evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 ; 49: 345-355
58. Sonuga-Barke EJS, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013 ; 170: 275-289
59. Stata Statistical Software: Release 11. College Station, Texas: StataCorp LP ; 2009 :
60. Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003 ; 38: 1007-1021
61. Stonehouse W, Conlon CA, Podd J, et al. DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial. Am J Clin Nutr. 2013 ; 97: 1134-1143
62. Su K-P, Lai H-C, Yang H-T, et al. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: Results from a randomized, controlled trial. Biol Psychiatry. 2014 ; 76: 559-566
63. Vaisman N, Kaysar N, Zaruk-adasha Y, et al. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention. Am J Clin Nutr. 2008 ; 87: 1170-1180
64. Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. Journal of Pediatrics. 2001 ; 139: 189-196
65. Wechsler D Manual for the Wechsler Scale of Children's Intelligence-III. New York: Psychological Corporation ; 1991 :
66. Widenhorn-Müller K, Schwanda S, Scholz E, et al. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled intervention trial. Prostaglandins Leukot Essent Fatty Acids. 2014 ; 91: 49-60
67. Willcutt EG, Pennington BF, Duncan L, et al. Understanding the complex etiologies of developmental disorders: Behavioral and molecular genetic approaches. J Dev Behav Pediatr. 2010 ; 31: 533-544
68. Wilkinson G, Roberts G Wide Range Achievement Test, Fourth Edition. Florida: Psychological Assessment Resources ; 2006 :
69. Yui K, Koshiba M, Nakamura S, et al. Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: A double-blind, placebo-controlled, randomized trial. J Clin Psychopharmacol. 2012 ; 32: 200-206